CUSABIO Expands Flexible Antibody Expression for AI-Driven Antibody Discovery

Positive

AI Analysis

Summary

CUSABIO has expanded its recombinant antibody expression service to support AI-driven antibody discovery with flexible options for 1 to 1,000+ sequences and expression scales from 3 mL to 20 mL, including optional validation techniques.

Importance:2/10

Sentiment:

0.30

antibody expressionAI-driven discoveryrecombinant antibodiesservice expansionprotein expression

Read the original article

Published by PR Newswire Biotech on September 23, 2026 1:00 PM

Read Original